Innospec Inc. (NASDAQ:IOSP) Q3 2021 Earnings Conference Call November 3, 2021 10:00 AM ET Company Participants David Jones - VP, General Counsel, Chief Compliance Officer and Corporate Secretary Patrick Williams - President and CEO Ian Cleminson - EVP and CFO Conference Call Participants Stefanos Crist - CJS Securities David Silver - CL King & Associates David Jones Hello, this is David Jones and I'm Innospec's General Counsel and Chief Compliance Officer. Yesterday, we reported our financial results for th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or other jurisdic ...

Innospec Inc. (NASDAQ:IOSP) Q2 2021 Earnings Conference Call August 4, 2021 10:10 AM ET Company Participants David Jones - Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary Patrick Williams - President, Chief Executive Officer and Director Ian Cleminson - Executive Vice President and Chief Financial Officer Conference Call Participants Peter Lucas - CJS Securities David Silver - CL King & Associates, Inc Christopher Shaw - Monness, Crespi, Hardt & Co., Inc Operator Good day. ...

innospec� chemistry matters Q2 2021 Earnings AUGUST 2021 Forward Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "could," "believes," "feels," "plans ...

Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or o ...

Innospec, Inc. (NASDAQ:IOSP) Q1 2021 Earnings Conference Call May 5, 2021 9:00 AM ET Company Participants David Jones - General Counsel, Chief Compliance Officer and Corporate Secretary Patrick Williams - President and CEO Ian Cleminson - EVP and CFO Conference Call Participants Jon Tanwanteng - CJS Securities. David Silver - C.L. King David Jones Thank you. This is David Jones. The Quarter One earnings release and this presentation will be available on the company's site for at least six months. During thi ...

innospec� chemistry matters Q1 2021 Earnings MAY 2021 Forward Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "could," "believes," "feels," "plan," " ...

Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 (State or ...

Innospec Inc. (NASDAQ:IOSP) Q4 2020 Results Earnings Conference Call February 17, 2021 9:00 AM ET Company Participants David Jones - General Counsel, Chief Compliance Officer, Corporate Secretary Patrick Williams - President, Chief Executive Officer Ian Cleminson - Executive Vice President, Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities. David Silver - C.L. King Chris Shaw - Monness, Crespi Operator Thank you all for standing by ladies and gentlemen. Welcome to today's ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITIONREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 State or other jurisdiction of incorporation or organ ...